Moscow, Russia

Sergei I Emelyanov

This inventor holds 1 USPTO granted patent. Top assignee: Vsesojuzny Kardiologichesky Nauchny Tsentr Akademii Meditsinskikh Nauk. Active years: 1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sergei I Emelyanov. Retrieved from https://idiyas.com/inventor/sergei-i-emelyanov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Sergei I Emelyanov

Introduction

Sergei I Emelyanov is a notable inventor based in Moscow, Russia. He has made significant contributions to the field of medical science, particularly through his innovative work in peptide research. His dedication to advancing healthcare solutions is evident in his patent portfolio.

Latest Patents

Emelyanov holds a patent for a hexapeptide, which showcases his expertise in biochemistry and its applications in medicine. This patent represents a crucial step in the development of therapeutic agents that can improve patient outcomes.

Career Highlights

Emelyanov is affiliated with the Vsesoyuzny Kardiologichesky Nauchny Tsentr Akademii Meditsinskikh Nauk, a leading research institution in cardiology. His work at this center has allowed him to focus on innovative research that addresses critical health issues.

Collaborations

Throughout his career, Emelyanov has collaborated with esteemed colleagues, including Mikhail I Titov and Zhanna D Bespalova. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Sergei I Emelyanov's contributions to the field of medical science through his patent and collaborative efforts highlight his commitment to innovation. His work continues to inspire advancements in healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…